Intellia Therapeutics
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.
2
Funding Rounds
$85.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ra**** Ha****** | - | - | |
| Lu***** Ma******** | - | - | - |
| Ro****** Ba******* | - | - | |
| Ne**** Be******** |
|
- | |
| Je****** Do**** |
|
- | linkedin twitter facebook instagram |
| Name | Phone | Social networks | |
|---|---|---|---|
| Je*********** Fo***** | - | - | |
| Jo** Le***** | - | - | |
| Je*** Go***** | - | - | - |
| Fr*** Ve***** | - | - | - |
| Ca****** Do*** | - | - | - |
| Jo** F. Cr***** | - | - | - |
| Fr** Co*** | - | - | |
| Mu** Bh**** | - | - | - |
| Ge***** Ke***** | - | - | - |
Industries
Intellia Therapeutics is active in the following industries:
- Therapeutics
- Biopharmaceutical
- Genetic engineering
- Cell therapy
- Immunotherapy
- Cancer immunotherapy
- Oncology
- Healthcare
- Consumer biotechnology
- Autoimmune disease
- Biomedical engineering
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Internal medicine
- Regenerative medicine
- Medicine
- Genomics
- Genome editing
- Tissue engineering
- Stem cell technology
- Engineering